Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Roivant Sciences leads the 154 health care companies ranked by P/S ratio, at 3397, ahead of Dianthus Therapeutics (2323) and CG Oncology (1769). Figures as of 19 Nov 2026, 13:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- First
- Roivant Sciences3397
- Median
- 4.3
- Combined market value
- ZAR 157.17T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Roivant SciencesROIV · Health Care | 3397 | ZAR 484.9B | ZAR 669.28 | 0.05% up | 91% up | ||
| 2 | Dianthus TherapeuticsDNTH · Health Care | 2323 | ZAR 81.7B | ZAR 1,451.22 | 3.45% down | 108% up | ||
| 3 | CG OncologyCGON · Health Care | 1769 | ZAR 123.5B | ZAR 1,382.45 | 1.34% up | 97% up | ||
| 4 | CRISPR TherapeuticsCRSP · Health Care | 1111 | ZAR 67.4B | ZAR 694.51 | 0.10% up | 18% down | ||
| 5 | Kymera TherapeuticsKYMR · Health Care | 264 | ZAR 178.7B | ZAR 2,093.20 | 0.32% down | 87% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | 180 | ZAR 143.4B | ZAR 2,197.40 | 2.00% up | 51% up | ||
| 7 | CytokineticsCYTK · Health Care | 81.2 | ZAR 123.5B | ZAR 886.84 | 0.64% down | 19% down | ||
| 8 | ImmunityBioIBRX · Health Care | 62.9 | ZAR 123.2B | ZAR 115.78 | 7.03% up | 232% up | ||
| 9 | Rhythm PharmaceuticalsRYTM · Health Care | 43.5 | ZAR 142.6B | ZAR 2,057.08 | 2.08% up | 18% up | ||
| 10 | InsmedINSM · Health Care | 43.3 | ZAR 454.2B | ZAR 2,070.22 | 1.69% down | 40% down | ||
| 11 | ModernaMRNA · Health Care | 41.0 | ZAR 1.38T | ZAR 3,400.65 | 4.84% down | 780% up | ||
| 12 | GRAILGRAL · Health Care | 31.2 | ZAR 79.3B | ZAR 1,764.35 | 3.57% down | 19% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | 30.3 | ZAR 262.6B | ZAR 1,348.06 | 1.58% up | 21% up | ||
| 14 | WatersWAT · Health Care | 28.9 | ZAR 1.58T | ZAR 8,054.49 | 3.63% up | 23% up | ||
| 15 | GlaukosGKOS · Health Care | 27.2 | ZAR 238.4B | ZAR 4,027.76 | 4.18% down | 145% up | ||
| 16 | Krystal BiotechKRYS · Health Care | 24.0 | ZAR 161.5B | ZAR 5,449.26 | 5.62% up | 54% up | ||
| 17 | HeartflowHTFL · Health Care | 22.9 | ZAR 69.7B | ZAR 793.01 | 2.51% down | 66% up | ||
| 18 | Ligand PharmaceuticalsLGND · Health Care | 22.3 | ZAR 103.3B | ZAR 5,161.89 | 1.67% up | 50% up | ||
| 19 | Ascendis PharmaASND · Health Care | 22.2 | ZAR 306.4B | ZAR 4,671.46 | 0.32% down | 29% up | ||
| 20 | Twist BioscienceTWST · Health Care | 21.1 | ZAR 137.1B | ZAR 2,010.60 | 3.88% up | 346% up | ||
| 21 | Guardant HealthGH · Health Care | 20.0 | ZAR 339.3B | ZAR 2,508.11 | 1.30% up | 45% up | ||
| 22 | Eli LillyLLY · Health Care | 18.9 | ZAR 21.28T | ZAR 23,894.75 | 2.32% down | 33% up | ||
| 23 | NateraNTRA · Health Care | 18.2 | ZAR 725.4B | ZAR 5,002.73 | 0.71% up | 28% up | ||
| 24 | Adaptive BiotechnologiesADPT · Health Care | 16.6 | ZAR 79.6B | ZAR 491.81 | 0.11% down | 74% up | ||
| 25 | Royalty PharmaRPRX · Health Care | 16.6 | ZAR 682.3B | ZAR 1,186.66 | 0.01% down | 79% up | ||
| 26 | TG TherapeuticsTGTX · Health Care | 16.2 | ZAR 172.7B | ZAR 1,142.59 | 5.44% up | 117% up | ||
| 27 | RepligenRGEN · Health Care | 15.0 | ZAR 190.7B | ZAR 2,983.84 | 6.47% up | 12% up | ||
| 28 | Intuitive SurgicalISRG · Health Care | 14.5 | ZAR 2.52T | ZAR 7,274.27 | 2.23% down | 24% down | ||
| 29 | BillionToOneBLLN · Health Care | 14.3 | ZAR 75.6B | ZAR 1,581.87 | 6.11% down | 4% down | ||
| 30 | argenxARGX · Health Care | 14.3 | ZAR 1.02T | ZAR 16,265.36 | 0.66% down | 2% up | ||
| 31 | IDEXX LaboratoriesIDXX · Health Care | 12.8 | ZAR 950.9B | ZAR 12,069.98 | 1.19% up | 1% up | ||
| 32 | 10x GenomicsTXG · Health Care | 11.7 | ZAR 129.7B | ZAR 986.20 | 1.37% up | 247% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | 11.6 | ZAR 104.3B | ZAR 1,598.28 | 0.59% up | 34% up | ||
| 34 | Vertex PharmaceuticalsVRTX · Health Care | 11.3 | ZAR 2.35T | ZAR 9,270.18 | 0.42% up | 27% up | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | 11.0 | ZAR 121.8B | ZAR 2,315.60 | 1.43% down | 6% down | ||
| 36 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | ZAR 129.1B | ZAR 1,642.52 | 0.06% down | 129% up | ||
| 37 | Edwards LifesciencesEW · Health Care | 10.0 | ZAR 1.05T | ZAR 1,818.44 | 0.19% down | 25% up | ||
| 38 | Travere TherapeuticsTVTX · Health Care | 9.8 | ZAR 83.3B | ZAR 868.18 | 1.68% down | 45% up | ||
| 39 | Corcept TherapeuticsCORT · Health Care | 9.7 | ZAR 128.2B | ZAR 1,171.45 | 3.25% down | 10% down | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | ZAR 159.8B | ZAR 6,879.06 | 5.67% down | 27% down | ||
| 41 | Bio-TechneTECH · Health Care | 9.4 | ZAR 197.5B | ZAR 1,257.16 | 0.17% up | 24% up | ||
| 42 | West Pharmaceutical ServicesWST · Health Care | 9.2 | ZAR 486.4B | ZAR 6,981.71 | 2.44% down | 57% up | ||
| 43 | PenumbraPEN · Health Care | 9.0 | ZAR 218.4B | ZAR 5,540.16 | 0.47% up | 15% up | ||
| 44 | BeOne MedicinesONC · Health Care | 8.6 | ZAR 796.7B | ZAR 6,974.45 | 2.34% down | 16% up | ||
| 45 | Mettler-Toledo InternationalMTD · Health Care | 8.6 | ZAR 597.1B | ZAR 30,020.90 | 1.42% up | 24% up | ||
| 46 | GenmabGMAB · Health Care | 8.4 | ZAR 543.1B | ZAR 880.79 | 1.91% down | 70% up | ||
| 47 | AbbVieABBV · Health Care | 8.3 | ZAR 8.74T | ZAR 4,942.42 | 2.33% down | 25% up | ||
| 48 | Halozyme TherapeuticsHALO · Health Care | 7.8 | ZAR 188.7B | ZAR 1,655.48 | 0.18% down | 39% up | ||
| 49 | United TherapeuticsUTHR · Health Care | 7.7 | ZAR 424.9B | ZAR 9,976.78 | 1.16% down | 22% up | ||
| 50 | Arrowhead PharmaceuticalsARWR · Health Care | 7.3 | ZAR 105.3B | ZAR 744.97 | 0.28% up | 13% up | ||
| 51 | IlluminaILMN · Health Care | 7.3 | ZAR 548.7B | ZAR 3,629.10 | 3.65% up | 76% up | ||
| 52 | Agilent TechnologiesA · Health Care | 7.2 | ZAR 864B | ZAR 3,064.37 | 2.97% up | 22% up | ||
| 53 | ExelixisEXEL · Health Care | 7.2 | ZAR 288B | ZAR 1,180.09 | 0.31% down | 63% up | ||
| 54 | Medpace HoldingsMEDP · Health Care | 7.2 | ZAR 312.7B | ZAR 11,178.30 | 0.95% down | 10% up | ||
| 55 | Gilead SciencesGILD · Health Care | 7.1 | ZAR 3.62T | ZAR 2,920.08 | 0.75% down | 35% up | ||
| 56 | Johnson & JohnsonJNJ · Health Care | 7.0 | ZAR 11.34T | ZAR 4,712.42 | 2.15% down | 34% up | ||
| 57 | Caris Life SciencesCAI · Health Care | 6.9 | ZAR 96.6B | ZAR 336.97 | 2.21% down | 19% down | ||
| 58 | Regeneron PharmaceuticalsREGN · Health Care | 6.8 | ZAR 1.69T | ZAR 16,339.33 | 1.28% down | 28% up | ||
| 59 | DexComDXCM · Health Care | 6.6 | ZAR 531.8B | ZAR 1,426.00 | 0.59% up | 41% up | ||
| 60 | DanaherDHR · Health Care | 6.5 | ZAR 2.78T | ZAR 3,950.00 | 1.24% up | 3% up | ||
| 61 | AmgenAMGN · Health Care | 6.5 | ZAR 4.15T | ZAR 7,670.69 | 3.07% down | 32% up | ||
| 62 | BioNTechBNTX · Health Care | 6.5 | ZAR 356.7B | ZAR 1,438.78 | 1.89% down | 14% down | ||
| 63 | HealthEquityHQY · Health Care | 6.1 | ZAR 139.1B | ZAR 1,681.58 | 4.45% down | 3% down | ||
| 64 | ResMedRMD · Health Care | 6.0 | ZAR 589.7B | ZAR 4,192.45 | 2.00% up | 1% down | ||
| 65 | RevvityRVTY · Health Care | 6.0 | ZAR 294.1B | ZAR 2,634.08 | 3.14% up | 62% up | ||
| 66 | Neurocrine BiosciencesNBIX · Health Care | 5.8 | ZAR 284.9B | ZAR 2,814.32 | 1.84% down | 17% up | ||
| 67 | Thermo Fisher ScientificTMO · Health Care | 5.8 | ZAR 4.44T | ZAR 11,970.96 | 0.87% up | 21% up | ||
| 68 | Alnylam PharmaceuticalsALNY · Health Care | 5.4 | ZAR 345.8B | ZAR 2,581.72 | 4.54% down | 66% down | ||
| 69 | NovartisNVS · Health Care | 5.4 | ZAR 5.07T | ZAR 2,682.12 | 2.46% down | 25% up | ||
| 70 | AlkermesALKS · Health Care | 5.3 | ZAR 136B | ZAR 809.60 | 3.08% up | 66% up | ||
| 71 | Merck & CoMRK · Health Care | 5.2 | ZAR 5.87T | ZAR 2,380.92 | 3.90% down | 45% up | ||
| 72 | QiagenQGEN · Health Care | 4.9 | ZAR 176.8B | ZAR 856.43 | 0.38% down | 9% up | ||
| 73 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | ZAR 78.8B | ZAR 473.32 | 1.59% up | 63% down | ||
| 74 | StrykerSYK · Health Care | 4.8 | ZAR 2.09T | ZAR 5,497.82 | 0.19% up | 12% down | ||
| 75 | AstraZenecaAZN · Health Care | 4.7 | ZAR 4.79T | ZAR 3,089.08 | 1.93% down | 1% up | ||
| 76 | IncyteINCY · Health Care | 4.7 | ZAR 414.9B | ZAR 2,035.65 | 1.08% down | 16% up | ||
| 77 | Lantheus HoldingsLNTH · Health Care | 4.3 | ZAR 115.3B | ZAR 1,762.62 | 0.20% up | 90% up | ||
| 78 | STERISSTE · Health Care | 4.2 | ZAR 435.6B | ZAR 4,485.53 | 0.84% up | 1% up | ||
| 79 | HaemoneticsHAE · Health Care | 4.2 | ZAR 96.7B | ZAR 2,123.09 | 1.60% up | 64% up | ||
| 80 | Abbott LaboratoriesABT · Health Care | 4.1 | ZAR 3.13T | ZAR 1,805.48 | 0.22% down | 16% down | ||
| 81 | Charles River Laboratories InternationalCRL · Health Care | 4.0 | ZAR 275.9B | ZAR 5,758.76 | 0.33% up | 106% up | ||
| 82 | Bio-Rad LaboratoriesBIO · Health Care | 3.9 | ZAR 172B | ZAR 6,396.76 | 3.34% up | 22% up | ||
| 83 | Novo NordiskNVO · Health Care | 3.8 | ZAR 3T | ZAR 681.37 | 3.12% down | 17% down | ||
| 84 | BiogenBIIB · Health Care | 3.8 | ZAR 642.2B | ZAR 4,344.52 | 0.25% up | 49% up | ||
| 85 | LivaNovaLIVN · Health Care | 3.8 | ZAR 90B | ZAR 1,633.71 | 2.85% up | 77% up | ||
| 86 | Jazz PharmaceuticalsJAZZ · Health Care | 3.7 | ZAR 274.8B | ZAR 4,281.61 | 2.93% up | 41% up | ||
| 87 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | ZAR 205.6B | ZAR 1,061.55 | 4.99% up | 17% up | ||
| 88 | LifeStance Health GroupLFST · Health Care | 3.7 | ZAR 90.5B | ZAR 237.95 | 2.82% down | 123% up | ||
| 89 | ZoetisZTS · Health Care | 3.7 | ZAR 600.8B | ZAR 1,478.70 | 2.50% up | 26% down | ||
| 90 | MSA SafetyMSA · Health Care | 3.6 | ZAR 118.1B | ZAR 3,066.44 | 2.67% up | 16% up | ||
| 91 | InsuletPODD · Health Care | 3.6 | ZAR 167.8B | ZAR 2,418.94 | 3.69% down | 55% down | ||
| 92 | MedtronicMDT · Health Care | 3.5 | ZAR 2.23T | ZAR 1,740.50 | 1.56% down | 1% up | ||
| 93 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | ZAR 215.8B | ZAR 258.86 | 1.28% up | 8% up | ||
| 94 | AlconALC · Health Care | 3.5 | ZAR 624.8B | ZAR 1,300.54 | 1.55% up | 0% up | ||
| 95 | Merit Medical SystemsMMSI · Health Care | 3.4 | ZAR 89B | ZAR 1,484.92 | 1.70% up | 1% up | ||
| 96 | TeleflexTFX · Health Care | 3.3 | ZAR 113.7B | ZAR 2,865.99 | 3.95% up | 58% up | ||
| 97 | Globus MedicalGMED · Health Care | 3.2 | ZAR 161.5B | ZAR 1,218.80 | 0.77% up | 14% down | ||
| 98 | Boston ScientificBSX · Health Care | 3.2 | ZAR 1.09T | ZAR 754.13 | 1.42% up | 55% down | ||
| 99 | Legend BiotechLEGN · Health Care | 3.1 | ZAR 54.5B | ZAR 280.81 | 0.87% up | 41% down | ||
| 100 | PTC TherapeuticsPTCT · Health Care | 2.9 | ZAR 87B | ZAR 1,040.81 | 0.22% down | 21% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2806 ZAR). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/S ratio?
Roivant Sciences (3397), Dianthus Therapeutics (2323) and CG Oncology (1769) are the top three of the 154 health care companies ranked by P/S ratio as of 19 Nov 2026, 13:15 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of ZAR 157.17T as of 19 Nov 2026, 13:15 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.